[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"telemedicine\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:telemedicine":27},{"pageToken":4,"total":5,"offset":6,"count":7,"results":8},null,26,0,25,[9,41,70,107,132,172,206,241,274,301,326,351,394,422,447,473,495,520,546,573,605,629,651,676,698],{"id":10,"slug":11,"hasResults":12,"nctId":13,"briefTitle":14,"officialTitle":15,"acronym":16,"eligibilityCriteria":17,"healthyVolunteers":18,"sex":19,"minAge":20,"maxAge":4,"enrollmentInfo":21,"targetDuration":4,"studyType":24,"phases":4,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":40},"100509762","the-actuate-cbc-study-100509762",false,"NCT05917652","The Actuate-CBC Study","THE Actuate-CBC Study: Accelerating the Uptake of Telemedicine for Crisis Burn Care","ACTUATE","Inclusion Criteria:\n\n* 18 years of age or older and\n* are providing burn care to patients at the 4 burn centers and the non-burnhospitals are eligible for inclusion.\n\nExclusion Criteria:\n\n* do not meet inclusion criteria,\n* decline to participate or do not give consent to participate in the study, •\n* directly express uneasiness about the participation",true,"ALL","18 Years",{"count":22,"type":23},2183,"ESTIMATED","OBSERVATIONAL","The study team will use implementation science to accelerate the uptake of teleconsultationfor burn patients by 1) examining the relationships between clinician perceptions of acceptability, feasibility, intention to use, and actual use of burn teleconsultation 2) identifying the optimal process for burn teleconsultation and the barriers and facilitators for its use during a crisis or prolonged care situation, and 3) designing and testing the effectiveness of a specific, tailored burn teleconsultation toolkit intervention to increase burn teleconsultation use.",[27],"Telemedicine","RECRUITING","2026-06-26",{"date":31,"type":32},"2026-06-29","ACTUAL",{"date":34,"type":32},"2023-01-04",{"date":36,"type":23},"2027-06-15",{"name":38,"class":39},"University of Pennsylvania","OTHER",4,{"id":42,"slug":43,"hasResults":12,"nctId":44,"briefTitle":45,"officialTitle":46,"acronym":4,"eligibilityCriteria":47,"healthyVolunteers":12,"sex":19,"minAge":20,"maxAge":4,"enrollmentInfo":48,"targetDuration":4,"studyType":50,"phases":51,"briefSummary":54,"conditions":55,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":60,"lastUpdatePostDateStruct":61,"startDateStruct":63,"completionDateStruct":65,"leadSponsor":67,"locationsCount":69},"100590813","phase-1-mindfulness-meditation-for-insomnia-100590813","NCT06972303","Mindfulness Meditation for Insomnia","A Pilot Feasibility and Acceptability RCT of an App-Based Mindfulness Meditation Intervention for Sleep Among Patients With Insomnia Disorder","Inclusion Criteria:\n\n* Age 18 years and older;\n* Chronic insomnia (≥ 3 nights\u002Fweek, for ≥ 3 months), defined by DSM-V or ICSD-3;\n* Have a primary complaint of difficulty falling asleep (sleep-onset insomnia) with self-reported sleep onset latency \\>20 min;\n* Insomnia Severity Index score ≥ 15;\n* Speak and understand English;\n* Have a smart device (phone or tablet) for mobile app installation\n\nExclusion Criteria:\n\n* Current diagnosis of sleep disorders other than insomnia (e.g., narcolepsy, restless leg syndrome, REM sleep behavior disorder, etc.);\n* Shift worker or routine night shifts;\n* Women with pregnancy or breastfeeding;\n* Regular (defined as twice a week or more) practice of mind-body interventions;\n* Patients with pace-maker or routinely using cardiovascular medications that have effects on heart rates (i.e., beta-blockers);\n* Neurological disorders (e.g. epilepsy, dementia, stroke, Parkinson's disease, neuroinfections, brain tumors, etc.) or current diagnosis of comorbid psychotic, substance use, and trauma-related disorders;\n* Currently under medications with sleep changing effects (e.g., anxiolytics\u002Fbenzodiazepines, selective serotonin reuptake inhibitors, hypnotics, etc.);\n* Hearing impairment or loss. Participants will be asked to report any medication for at least 2 weeks prior to study onset and during the study period.",{"count":49,"type":23},30,"INTERVENTIONAL",[52,53],"PHASE1","PHASE2","The investigators will conduct a 3-arm, pilot RCT where participants (N=30) will be randomized in a 1:1:1 design to 4 weeks of instructed bedtime MM practice at night (n=10) vs. uninstructed MM (n=10) vs. sleep hygiene education only (n=10). Aim 1 is to understand the feasibility and acceptability of the intervention and study procedures. Aim 2 is to explore patterns of within-group changes in sleep outcomes (i.e., insomnia severity and sleep quality). Patient-reported outcomes will be collected using a HIPAA-compliant electronic data management system (REDCap). Following informed consent, participants will receive links to REDCap surveys via email at Weeks 0, 4, 8, and 16. The investigators will also conduct a post-intervention interview at the end of Week 4 and an exit interview at Week 16. All participants will also receive a research kit with wearable devices and meet with our staff after they receive the kit for instructions. Data collected in the pilot RCT will help us to preliminarily identify tools for subjective measures and physiological signals to inform a future trial.",[56,57,58,59,27],"Sleep Initiation and Maintenance Disorders","Insomnia","Insomnia Chronic","Mindfulness","2026-06-21",{"date":62,"type":32},"2026-06-23",{"date":64,"type":32},"2026-03-31",{"date":66,"type":23},"2028-12-29",{"name":68,"class":39},"Brigham and Women's Hospital",1,{"id":71,"slug":72,"hasResults":12,"nctId":73,"briefTitle":74,"officialTitle":75,"acronym":4,"eligibilityCriteria":76,"healthyVolunteers":12,"sex":19,"minAge":20,"maxAge":4,"enrollmentInfo":77,"targetDuration":4,"studyType":50,"phases":79,"briefSummary":81,"conditions":82,"keywords":86,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":97,"lastUpdatePostDateStruct":98,"startDateStruct":100,"completionDateStruct":102,"leadSponsor":104,"locationsCount":69},"100642808","anchor-validation-trial-in-high-risk-multidisciplinary-care-100642808","NCT07597499","ANCHOR Validation Trial in High-Risk Multidisciplinary Care","ANCHOR (Auditable Navigation of Clinical Hazards With Oversight and Reasoning) Multicenter Randomized Validation Study: A Pragmatic Three-Arm (1:1:1) Patient-Level Randomized Controlled Trial of a Structural Verification Layer for AI-Assisted High-Risk Multidisciplinary Care Across Three U.S. States","INCLUSION CRITERIA:\n\n1. Age 18 years or older.\n2. Attributed to a participating Waymark provider (academic medical center, community-hospital network, federally qualified health center, or independent physician practice in Ohio, Washington, or Virginia; full TIN-consolidated list deposited at the Open Science Framework).\n3. Meets high-risk multidisciplinary criteria (combined claims-based and clinical: 2 or more emergency-department visits or 1 or more hospitalization in the prior 12 months, 5 or more active medications, 2 or more active specialist relationships, 2 or more chronic conditions, or claims-based equivalents).\n4. Encounter occurs in one of the three Waymark service modalities: high-risk primary care, specialty care coordination, or real-time telemedicine urgent care.\n5. English-language clinical documentation.\n6. Encounter requires clinical reasoning (not administrative-only).\n\nEXCLUSION CRITERIA:\n\n1. Pediatric (age less than 18 years).\n2. Hospice or palliative-care-exclusive care plan.\n3. Active psychiatric crisis routed to crisis line.\n4. Encounter is administrative only.\n5. Pharmacy-only encounter that does not surface a clinical decision to the supervising physician.\n6. Encounter where the supervising physician is the principal investigator.\n7. Patient enrolled in a competing AI-safety study within the prior 90 days.",{"count":78,"type":23},240,[80],"NA","This pre-registered, pragmatic, three-arm (1:1:1) patient-level randomized controlled trial with mixed-effects analysis at the encounter level tests two questions in real high-risk multidisciplinary clinical encounters at the Waymark clinically integrated network across three U.S. states (Ohio, Washington, Virginia): (1) does adding ANCHOR - a clinical AI structural verification layer - to a Gemini 3.1 Pro-assisted supervising-physician workflow reduce the rate of clinically meaningful safety failures, compared with the same Gemini 3.1 Pro-assisted workflow without ANCHOR? (2) does the Gemini 3.1 Pro-assisted workflow itself reduce the same safety endpoint compared with unassisted standard care in which the supervising physician writes their own SOAP assessment\u002Fplan from a blank template?\n\nANCHOR is a single-call structural verification layer combining a Logical Neural Network (Riegel et al. 2020) certificate, six specialist agents, and concept-decomposed output with PMID citation provenance. ANCHOR is physician-facing only and is used by supervising physicians, not by the multidisciplinary clinical team they oversee.\n\nThe trial randomizes 240 patients 1:1:1 across the Waymark clinically integrated network over a 12-week active-enrolment window (80 per arm). Eligible patients are adults (age 18+) identified as high-risk by combined claims-based and clinical criteria. Eligible encounters span three integrated Waymark service modalities: high-risk primary care, specialty care coordination, and real-time telemedicine urgent care. The primary endpoint is a per-encounter binary composite: any of (a) failure to mention a do-not-miss diagnosis, (b) under-triage, (c) contraindicated medication recommendation, (d) failure to recommend escalation when clinically warranted; adjudicated by a blinded panel of 3 board-certified physicians with majority-of-three scoring. The primary contrast is Arm 3 (LLM+ANCHOR) versus Arm 2 (LLM with safety prompt), isolating ANCHOR's marginal contribution over a deployment-equivalent LLM safety stack. The pre-specified secondary contrast is Arm 2 versus Arm 1.\n\nThe trial is sized to the operational ceiling of the Waymark integrated-network workflow across the three states (240 enrollees over 12 weeks). At realistic effect sizes derived from the retrospective evaluation, the trial is underpowered for definitive efficacy declaration on either pairwise contrast and is reported as an initial deployment-feasibility validation cohort with effect estimates and 95 percent confidence intervals; full power calculations are pre-registered in the Statistical Analysis Plan.\n\nSingle-blind outcome adjudication: 3 adjudicators score only the supervising physician's final clinical decision, so all three arms produce adjudication packets in identical format and arm allocation is structurally invisible. Statisticians remain blinded until database lock. A full waiver of informed consent is requested per 45 CFR 46.116(f)(3) with a companion HIPAA waiver of authorization under 45 CFR 164.512(i)(2)(ii). The study is registered on the Open Science Framework prior to first enrollment and reported under CONSORT-AI 2020.",[83,84,85,27],"High-Risk Multidisciplinary Care","Clinical Decision Support","Artificial Intelligence-Assisted Care",[87,88,89,90,91,92,93,94,95,96],"clinical decision support","large language model","artificial intelligence","verification layer","logical neural network","care management","telemedicine","patient safety","algorithmic fairness","CONSORT-AI","2026-06-04",{"date":99,"type":32},"2026-06-09",{"date":101,"type":32},"2026-05-15",{"date":103,"type":23},"2026-12",{"name":105,"class":106},"Waymark","INDUSTRY",{"id":108,"slug":109,"hasResults":12,"nctId":110,"briefTitle":111,"officialTitle":111,"acronym":112,"eligibilityCriteria":113,"healthyVolunteers":12,"sex":19,"minAge":114,"maxAge":115,"enrollmentInfo":116,"targetDuration":4,"studyType":50,"phases":118,"briefSummary":119,"conditions":120,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":123,"lastUpdatePostDateStruct":124,"startDateStruct":126,"completionDateStruct":128,"leadSponsor":130,"locationsCount":69},"100565159","integrating-telehealth-to-advance-lung-cancer-screening-100565159","NCT06638554","Integrating Telehealth to Advance Lung Cancer Screening","ITALCS","Inclusion criteria:\n\nParticipants will be eligible if:\n\n1. are aged 50 to 80\n2. have a history of tobacco use indicated by either: Documented 20 pack-year or greater smoking history in their electronic health record (EHR); OR Self-report via structured survey\n3. currently smoke or formerly smoked cigarettes\n4. have no documented history of lung cancer\n5. have no documented history of lung cancer screening in the 24 months prior to study enrollment\n6. have completed at least one primary care visit at Penn Medicine in the 3 years prior to study enrollment.\n\nExclusion criteria:\n\nParticipants who do not meet inclusion criteria will not be eligible.","50 Years","80 Years",{"count":117,"type":23},6000,[80],"The goal of this pragmatic trial is to learn if telehealth strategies can increase shared decision-making (SDM) for lung cancer screening (LCS). It will also learn about the equity of these strategies by conducting non-inferiority analysis by race and sex. The main questions it aims to answer are:\n\n1. Does patient outreach using synchronous and asynchronous telehealth strategies increase completion of SDM visits for LCS?\n2. Is the effectiveness of these telehealth strategies similar by race and sex?\n\nThe study uses a Sequential Multiple Assignment Randomized Trial (SMART) design and includes two stages of interventions. The first stage of intervention includes direct patient outreach with an invitation to schedule either a 1) telehealth SDM visit or 2) telehealth or in-person SDM visit. Participants that do not respond to the first stage interventions receive a text message reminder encouraging SDM visit completion with or without digital care coordination.",[121,27,122],"Early Detection of Cancer","Decision Making","2026-05-27",{"date":125,"type":32},"2026-05-29",{"date":127,"type":32},"2024-07-09",{"date":129,"type":23},"2027-06-30",{"name":131,"class":39},"Abramson Cancer Center at Penn Medicine",{"id":133,"slug":134,"hasResults":12,"nctId":135,"briefTitle":136,"officialTitle":137,"acronym":138,"eligibilityCriteria":139,"healthyVolunteers":12,"sex":19,"minAge":20,"maxAge":4,"enrollmentInfo":140,"targetDuration":4,"studyType":50,"phases":142,"briefSummary":143,"conditions":144,"keywords":158,"overallStatus":161,"whyStopped":4,"lastUpdateSubmitDate":162,"lastUpdatePostDateStruct":163,"startDateStruct":165,"completionDateStruct":167,"leadSponsor":169,"locationsCount":171},"100640479","reaction-vad-trial-remote-exercise-training-via-telemedicine-in-patients-with-long-term-ventricular-assist-devices-100640479","NCT07611188","REACTION-VAD Trial: Remote Exercise Training Via Telemedicine in Patients With Long-Term Ventricular Assist Devices","Efficacy and Safety of a Remote Conditioning Program in Patients Supported With a Ventricular Assist Device: THE RE-ACTION-VAD TRIAL.","REACTION-VAD","Inclusion Criteria (must meet all):\n\n* Recent LVAD Implantation (\\\u003C6 months)\n* Clinical stability (defined as meeting all of the following criteria): discharge from the LVAD implantation hospitalization, absence of inotropic medication, hemoglobin \\>9 g\u002FdL, and no active infection.\n* Inability to participate in a supervised rehabilitation program (due to lack of availability, or inability because geographical reasons).\n\nExclusion Criteria (any):\n\n* Functional Inability to Perform Cardiopulmonary Exercise Testing\n* Prior Participation in a Supervised Rehabilitation Program (after the LVAD implantation)",{"count":141,"type":23},78,[80],"Current international guidelines recommend that patients with a heart pump (left ventricular assist device, LVAD) participate in supervised exercise cardiac rehabilitation programs. However, not all patients with a heart pump are able to attend to a supervised program on a daily basis.\n\nThe goal of this clinical trial is to determine whether a home-based exercise program helps patients with a heart pump improve their exercise capacity and quality of life, guided by telemedicine tools including a mobile app, smartwatch, and remote medical checkups. The study will also provide information about the safety of this program by monitoring for any issues or symptoms during home activity.\n\nThe trial aims to answer the following questions:\n\n* Does a 12-week remote exercise program improve patients' exercise capacity? This will be measured using the 6-minute walk test and a cardiopulmonary exercise test.\n* Is it safe for patients to follow this exercise plan at home while being monitored through a mobile app and smartwatch?\n* Does the program improve quality of life and reduce feelings of anxiety or depression? This will be assessed using widely validated questionnaires, such as the Kansas City Cardiomyopathy Questionnaire.\n\nResearchers will compare the remote exercise program to standard care, which usually does not include exercise for patients who are unable to attend the hospital daily.\n\nParticipants will:\n\n* Join the study voluntarily after signing a consent form.\n* Be randomly assigned, with a 50% chance of being in either the exercise group (following a structured plan with a mobile app) or the usual care group (receiving general written advice), to see which approach works best for recovery.\n* Follow a 12-week home-based routine if in the exercise group, including warm-up routine, walking or cycling, respiratory exercises, and light strength training, all supported by the mobile app, smartwatch, and professional monitoring.\n* Visit the hospital three times over six months for medical checkups, including walking and exercise tests, blood analyses, and questionnaires about physical and emotional health.",[145,146,147,148,149,27,150,151,152,153,154,155,156,157],"Heart Failure","Advanced Heart Failure","Left Ventricular Assist Device","LVAD","Cardiac Rehabilitation","Remote Exercise","Ventricular Assist Device","Exercise Training","Conditioning Therapy","Cardiopulmonary Exercise Test","Six Minute Walk Test","Quality of Life","Telerehabilitation",[147,146,145,149,159,27,160,156,154,157],"Remote rehabilitation","6 minute walking test","NOT_YET_RECRUITING","2026-05-20",{"date":164,"type":32},"2026-05-28",{"date":166,"type":23},"2026-05",{"date":168,"type":23},"2030-12",{"name":170,"class":39},"Puerta de Hierro University Hospital",10,{"id":173,"slug":174,"hasResults":12,"nctId":175,"briefTitle":176,"officialTitle":177,"acronym":178,"eligibilityCriteria":179,"healthyVolunteers":12,"sex":180,"minAge":20,"maxAge":4,"enrollmentInfo":181,"targetDuration":4,"studyType":50,"phases":183,"briefSummary":184,"conditions":185,"keywords":189,"overallStatus":161,"whyStopped":4,"lastUpdateSubmitDate":197,"lastUpdatePostDateStruct":198,"startDateStruct":200,"completionDateStruct":202,"leadSponsor":204,"locationsCount":69},"100634631","pre-anesthetic-teleconsultations-during-pregnancy-100634631","NCT07542197","Pre-anesthetic Teleconsultations During Pregnancy","ECO-CAM: Pre-anesthetic Consultations During Pregnancy: Benefits of Teleconsultation for Patient Assessment, Information, and Ecological Impact","ECO-CAM","Inclusion Criteria:\n\n* Pregnant patients scheduled to give birth at the Bordeaux University Hospital, ASA score 1 or 2, for their primary pregnancy, who have booked an anesthesia appointment on one of the half-days when teleconsultation is available in the department\n* Have access to the internet and functional computer equipment (smartphone, computer)\n* Have a valid email address and telephone number\n\nExclusion Criteria:\n\n* Minor patient (under 18 years old at the time of inclusion)\n* Individuals not affiliated with or beneficiaries of a social security scheme\n* Patients who do not speak French\n* Persons under legal guardianship\n* Psychiatric conditions that impair the ability to consent to or participate in the study\n* Severe spinal pathology (scoliosis requiring a brace or surgery, ankylosing spondylitis), history of spinal surgery\n* Comorbidities with ASA score ≥3","FEMALE",{"count":182,"type":23},250,[80],"Quality of teleconsultation in comparison to face-to-face consultation for pre anesthetic evaluation in pregnant persons before delivery will be evaluated. Quality is evaluated with a composite criterion comprising 7 elements required for security of anesthesia. Discordance between this composite criterion during the pre anesthesia visit the day of delivery and pre anesthesia consultation several weeks before delivery will be assessed.",[186,187,188,27],"Pregnancy","Anesthesia","Satisfaction",[190,191,192,193,194,195,196,93],"pre anesthetic consultation","anesthesia","obstetrics","carbon footprint","e-health","electronic medical records","telehealth","2026-04-22",{"date":199,"type":32},"2026-04-28",{"date":201,"type":23},"2026-06-30",{"date":203,"type":23},"2028-06",{"name":205,"class":39},"University Hospital, Bordeaux",{"id":207,"slug":208,"hasResults":12,"nctId":209,"briefTitle":210,"officialTitle":211,"acronym":4,"eligibilityCriteria":212,"healthyVolunteers":12,"sex":19,"minAge":114,"maxAge":4,"enrollmentInfo":213,"targetDuration":4,"studyType":50,"phases":215,"briefSummary":216,"conditions":217,"keywords":224,"overallStatus":161,"whyStopped":4,"lastUpdateSubmitDate":232,"lastUpdatePostDateStruct":233,"startDateStruct":235,"completionDateStruct":237,"leadSponsor":239,"locationsCount":4},"100628632","evaluation-of-dora-care-for-supporting-fracture-liaison-services-fls-100628632","NCT07464171","Evaluation of Dora Care for Supporting Fracture Liaison Services (FLS)","A Prospective, Mixed-Methods Feasibility Study to Evaluate the Agreement, Safety, and Acceptability of 'Dora Care', an Automated AI Voice Assistant, for Supporting Clinical Pathways in a Fracture Liaison Service.","Inclusion Criteria:\n\n* Access to and ability to use a telephone for automated conversations as part of a routine, FLS phone pathway. This includes patients who are:\n* Adults aged ≥50 years.\n* Presenting with a new fragility fracture requiring FLS assessment.\n* Able to provide informed consent.\n* English speaking.\n* Reside in the UK.\n\nExclusion Criteria:\n\n* Severe cognitive impairment precluding meaningful telephone interaction or informed consent.\n* Patients already established on long-term osteoporosis treatment.\n* Terminal illness with a life expectancy \\\u003C12 months.\n* Current participation in another clinical trial altering standard of care thus altering the care schedule.",{"count":214,"type":23},217,[80],"What is the study about? This study is testing \"Dora\", an AI-powered assistant that can make phone calls to patients, for use in the Fracture Liaison Service (FLS). The FLS is a clinic that helps prevent more bone fractures after an initial \"fragility fracture\" (a break that happens easily, usually due to osteoporosis).\n\nWhy is this being done? FLS clinicians often have to spend a lot of time on routine phone calls for assessments and follow-ups. If Dora can safely and accurately collect patient information, it might save time for staff and still give patients a good experience.\n\nWhat will happen to patients in the study? Invitation and consent - Patients with a new fragility fracture who are eligible will be invited to take part after informed consent.\n\nDora call - Patients will receive an automated phone call from Dora, at the start of their FLS pathway and at follow-up.\n\nAt intake, Dora will ask about risk factors for bone problems (e.g., smoking, alcohol use, family fracture history).\n\nAt follow-up, Dora will ask about medication use, side effects, falls, or new fractures.\n\nClinician call - Soon after, patients will have their usual phone appointment with an FLS clinician, who asks similar questions.\n\nSurveys\u002Finterviews - Patients will be asked to complete a short questionnaire and take part in an optional interview to say how they felt about talking to Dora.\n\nWhat about clinicians? Clinicians involved in the FLS pathway will be asked to complete a short survey and to take part in an optional interview to understand how useful Dora's reports might be in their work.\n\nWho can take part? Patients - Age 50+, English-speaking, with a new fragility fracture, and able to use the phone.\n\nClinicians - Those working in FLS or similar bone health services. How long will it take? Each patient might be involved for up to about 7 months. The whole study will take about a year.",[218,219,220,27,221,222,223],"AI (Artificial Intelligence)","Osteoporosis","Outpatient","Automation","Risk Assesment","Bone Health",[218,225,226,227,228,229,27,223,230,231],"Fracture Liason Services","Conversational AI","Triage","Rheumatology","Telephone Consultation","Voice AI","Medical Device","2026-03-05",{"date":234,"type":32},"2026-03-11",{"date":236,"type":23},"2026-02",{"date":238,"type":23},"2027-12",{"name":240,"class":106},"Ufonia",{"id":242,"slug":243,"hasResults":12,"nctId":244,"briefTitle":245,"officialTitle":246,"acronym":247,"eligibilityCriteria":248,"healthyVolunteers":12,"sex":19,"minAge":20,"maxAge":4,"enrollmentInfo":249,"targetDuration":4,"studyType":50,"phases":251,"briefSummary":252,"conditions":253,"keywords":258,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":265,"lastUpdatePostDateStruct":266,"startDateStruct":268,"completionDateStruct":270,"leadSponsor":272,"locationsCount":69},"100588092","virtual-ward-for-early-discharge-in-patients-receiving-inpatient-care-100588092","NCT06936891","Virtual Ward for Early Discharge in Patients Receiving Inpatient Care","Virtual Ward for Early Discharge in Patients Receiving Inpatient Care: A Prospective Feasibility Study on Home Monitoring for the Early Discharge of Eligible Hospitalized Patients in an Outpatient Setting","VIP care","Inclusion Criteria:\n\n* Adult patients (≥18 years old).\n* Currently hospitalized and eligible for early discharge according to clinical judgment.\n* Ability to provide written informed consent.\n* Access to a smartphone or tablet with internet connection.\n* Patient is capable of using the Digizorg app or has support from a caregiver who can assist.\n* Suitable home situation for Virtual Ward care (e.g., safe environment, necessary utilities available).\n* Enrollment in one of the predefined Virtual Ward care pathways\n\nExclusion Criteria:\n\n* Patients requiring continuous hospital-based monitoring or interventions that cannot be safely delivered at home.\n* Patients who are hemodynamically unstable or require oxygen therapy \\>5 liters\u002Fminute at the time of discharge.\n* Patients unable or unwilling to comply with home monitoring procedures.\n* Patients with significant cognitive impairment without adequate caregiver support.\n* Patients with a life expectancy less than 30 days, as assessed by the treating physician.\n* Patients participating in another interventional clinical trial that could interfere with the Virtual Ward protocol.\n* Any other condition that, in the opinion of the treating physician, would make participation unsafe or infeasible.",{"count":250,"type":23},306,[80],"This study evaluates the feasibility of providing hospital-level care at home for eligible patients through a Virtual Ward. Patients are discharged early from the hospital and monitored remotely using digital vital sign monitoring and anamnesis questionnaires. The primary aim is to determine if at least 30% of eligible patients can be safely and successfully transferred to the Virtual Ward under current Dutch healthcare conditions.",[254,27,255,256,257],"Early Discharge","Virtual Clinic","Hospital at Home","Feasibility Studies",[259,93,260,261,262,263,264],"early discharge","virtual ward","virtual clinic","hospital at home","feasability","telemonitoring","2026-02-15",{"date":267,"type":32},"2026-02-17",{"date":269,"type":32},"2025-04-16",{"date":271,"type":23},"2028-12-31",{"name":273,"class":39},"Erasmus Medical Center",{"id":275,"slug":276,"hasResults":12,"nctId":277,"briefTitle":278,"officialTitle":279,"acronym":4,"eligibilityCriteria":280,"healthyVolunteers":12,"sex":19,"minAge":20,"maxAge":4,"enrollmentInfo":281,"targetDuration":283,"studyType":24,"phases":4,"briefSummary":284,"conditions":285,"keywords":287,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":292,"lastUpdatePostDateStruct":293,"startDateStruct":295,"completionDateStruct":297,"leadSponsor":299,"locationsCount":69},"100577855","public-perceptions-toward-robotic-surgery-telesurgery-and-telemedicine-100577855","NCT06803719","Public Perceptions Toward Robotic Surgery, Telesurgery and Telemedicine","Public Awareness, Trust, and Risk Perception Toward Robotic Surgery, Telesurgery and Telemedicine","Inclusion Criteria:\n\n* Chinese citizens aged 18 years or older\n* Able to understand and complete the questionnaire\n* Voluntarily participating in this study and providing informed consent\n\nExclusion Criteria:\n\n* Aged below 18 years\n* Unable to understand the questionnaire or unable to complete the questionnaire independently\n* Those who submit the questionnaire repeatedly",{"count":282,"type":23},1000,"6 Months","This study aims to systematically assess the public's and clinicians' levels of awareness, attitudes, risk perception, acceptance, and potential concerns regarding robotic surgery and telesurgery. It also analyzes the key factors influencing their attitudes and explores the needs of physicians regarding training systems for robotic and telesurgery, as well as the factors affecting their preparedness.",[286,27],"Robotic Surgery",[288,289,290,291],"Public perception","Telemedicine adoption","Surgical training","Surgical decision-making","2025-12-31",{"date":294,"type":32},"2026-01-02",{"date":296,"type":32},"2024-11-01",{"date":298,"type":23},"2027-12-31",{"name":300,"class":39},"Shanghai 6th People's Hospital",{"id":302,"slug":303,"hasResults":12,"nctId":304,"briefTitle":305,"officialTitle":306,"acronym":307,"eligibilityCriteria":308,"healthyVolunteers":12,"sex":19,"minAge":309,"maxAge":115,"enrollmentInfo":310,"targetDuration":4,"studyType":50,"phases":311,"briefSummary":312,"conditions":313,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":316,"lastUpdatePostDateStruct":317,"startDateStruct":319,"completionDateStruct":321,"leadSponsor":323,"locationsCount":325},"100588525","effect-of-visual-feedback-from-the-spirogym-mobile-application-100588525","NCT06942533","Effect of Visual Feedback From the SpiroGym Mobile Application","The Effect of Visual Feedback From the SpiroGym Mobile Application on Expiratory Muscle Strength Training Performance in Patients With Parkinson's Disease","EXPARK","Inclusion Criteria:\n\n* Diagnosis of Parkinsons disease\n* Stable dopaminergic medication (stable dose for at least 1 month)\n\nExclusion Criteria:\n\n* Other neurological disorders\n* Significant cognitive impairment\n* Major psychiatric disorder\n* History of head or neck cancer or previous surgical interventions in the neck region.\n* Illness during the study period","40 Years",{"count":49,"type":23},[80],"The previous pilot study showed that two weeks of intensive expiratory muscle strength training (EMST) with SpiroGym was sufficient to significantly improve voluntary peak cough flow (PCF). The improvement was quantitatively comparable to that reported in other intensive EMST studies of longer duration. To explain this rapid improvement, we considered the potential contribution of SpiroGym's visual feedback. We assumed that real-time visual feedback increased training effort compared with conventional EMST performed without immediate feedback.\n\nThe aim of this study is to evaluate the effect of visual feedback provided by the SpiroGym mobile application on performance during expiratory muscle strength training in patients with Parkinson's disease.",[314,315,27],"Parkinson Disease","Breathing Exercises","2025-11-24",{"date":318,"type":32},"2025-12-01",{"date":320,"type":32},"2025-05-01",{"date":322,"type":23},"2026-07-01",{"name":324,"class":39},"General University Hospital, Prague",2,{"id":327,"slug":328,"hasResults":12,"nctId":329,"briefTitle":330,"officialTitle":331,"acronym":4,"eligibilityCriteria":332,"healthyVolunteers":12,"sex":19,"minAge":20,"maxAge":4,"enrollmentInfo":333,"targetDuration":4,"studyType":50,"phases":335,"briefSummary":336,"conditions":337,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":342,"lastUpdatePostDateStruct":343,"startDateStruct":345,"completionDateStruct":347,"leadSponsor":349,"locationsCount":69},"100613319","integrated-tcm---western-medicine-strategy-for-long---distance-diabetes-management-100613319","NCT07265037","Integrated TCM - Western Medicine Strategy for Long - Distance Diabetes Management","Development of a New Integrated Strategy for Long-Distance and Full-Course Management of Diabetes Using Both Traditional Chinese and Western Medicine: A Combined Online and Offline Approach","Inclusion Criteria:\n\n* Presence of typical diabetes symptoms (polyuria, polydipsia, polyphagia, and unexplained weight loss) AND meeting any one of the following laboratory criteria: Fasting venous plasma glucose ≥ 7.0 mmol\u002FL, or Random plasma glucose ≥ 11.1 mmol\u002FL, or Glycated hemoglobin (HbA1c) ≥ 6.5%.\n* OR, meeting the following oral glucose tolerance test criteria:Fasting plasma glucose ≥ 7.0 mmol\u002FL AND 2-hour plasma glucose ≥ 11.1 mmol\u002FL after a 75g glucose load.\n\nExclusion Criteria:\n\n* Comorbidities that may prevent compliance with the study protocol, including but not limited to: active malignancy, rheumatic autoimmune diseases, severe infections, multiple organ failure, or psychiatric disorders.",{"count":334,"type":23},10000,[80],"The management of diabetes is of great value in reducing the risk of complications and alleviating the socioeconomic burden. Currently, the diabetes management models in China have not effectively integrated the advantages of traditional Chinese medicine (TCM) and Western medicine. They also fail to achieve intelligent and automated management, resulting in high management costs and low efficiency. Therefore, it is extremely urgent to explore a new, efficient, convenient, low - cost, and personalized long - distance, full - course, intelligent management model for diabetes that integrates TCM and Western medicine both online and offline.\n\nBased on this, our research group plans to rely on the pre - designed and developed Idata database. We will deeply integrate the diagnostic and treatment advantages of TCM constitution differentiation and Western medical examinations and laboratory tests, construct an automated follow - up path, and build an integrated online diabetes management platform for Internet hospitals, which consists of \"intelligent hardware + APP + cloud services + a back - end think - tank of TCM and Western medicine experts + a back - end professional management and care team\".\n\nThis initiative aims to blaze a new trail in the field of long - distance, full - course, and personalized management of diabetes through the synergy of TCM and Western medicine for Chinese diabetes patients. We expect to significantly reduce the incidence of diabetes complications, remarkably improve the overall health status and quality of life of patients, and bring unprecedented positive impacts on the well - being of diabetes patients.",[338,339,27,340,341],"Diabetes Mellitus, Type 2","Integrated Traditional Chinese Medicine and Western Medicine","Chronic Disease Management","Digital Health","2025-11-23",{"date":344,"type":32},"2025-12-04",{"date":346,"type":32},"2025-11-01",{"date":348,"type":23},"2026-05-31",{"name":350,"class":39},"Shanxi Bethune Hospital",{"id":352,"slug":353,"hasResults":12,"nctId":354,"briefTitle":355,"officialTitle":355,"acronym":356,"eligibilityCriteria":357,"healthyVolunteers":12,"sex":19,"minAge":20,"maxAge":4,"enrollmentInfo":358,"targetDuration":4,"studyType":50,"phases":360,"briefSummary":361,"conditions":362,"keywords":384,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":385,"lastUpdatePostDateStruct":386,"startDateStruct":388,"completionDateStruct":390,"leadSponsor":392,"locationsCount":69},"100585650","digital-transformation-of-continuity-of-care-for-peripherally-inserted-central-catheters-spadcare-experience-100585650","NCT06905119","Digital Transformation of Continuity of Care for Peripherally Inserted Central Catheters: SpadCare Experience","SpadCare","Inclusion Criteria:\n\n* Patients \\>18 years.\n* Sign the informed consent form.\n* Have a Smartphone and accept the use of the APP.\n* Patient with a PICC inserted by the Infusion and Vascular Access Team of the University Hospital of Navarra and with a planned use of at least one month.\n\nExclusion Criteria:\n\n* Patients with limitations in the use of digital resources or lack of Smartphone.\n* Patients who do not want to install the APP on their Smartphone\n* Patients who do not authorize access to their Computerized Medical Record (HCI).",{"count":359,"type":23},201,[80],"The study focuses on patients who require outpatient infusion of therapy (\"Infusions, Intravenous\"\\[Mesh\\]) \"Administration, Intravenous\"\\[Mesh\\] (\"Home Infusion Therapy\"\\[Mesh\\]) \"Parenteral Nutrition, Home\"\\[Mesh\\] via a peripherally inserted central catheter (PICC) (\"Central Venous Catheters\"\\[MeSH\\] \"Catheterization, Central Venous\"\\[MeSH\\] \"Catheterization, Peripheral\" \\[MeSH\\] \"Vascular Access Devices\"\\[Mesh\\] )",[363,364,365,366,367,368,369,370,371,372,373,374,375,376,341,377,378,379,380,381,382,383,27],"Infusions, Intravenous","Administration, Intravenous","Home Infusion Therapy","Parenteral Nutrition, Home","Central Venous Catheters","Catheterization, Central Venous","Catheterization, Peripheral","Vascular Access Devices","Patient Education as Topic","Patient Participation","User-Computer Interface","Smartphone","Mobile Applications","Computers, Handheld","Nursing","Care Givers","Delivery of Health Care","Home Nursing","Self Administration","Adverse Effects","Catheter-Related Infections",[369,370,371,27,375],"2025-09-11",{"date":387,"type":32},"2025-09-12",{"date":389,"type":32},"2023-05-04",{"date":391,"type":23},"2026-07-31",{"name":393,"class":39},"Fundacion Miguel Servet",{"id":395,"slug":396,"hasResults":12,"nctId":397,"briefTitle":398,"officialTitle":399,"acronym":4,"eligibilityCriteria":400,"healthyVolunteers":12,"sex":19,"minAge":401,"maxAge":4,"enrollmentInfo":402,"targetDuration":4,"studyType":50,"phases":404,"briefSummary":405,"conditions":406,"keywords":409,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":413,"lastUpdatePostDateStruct":414,"startDateStruct":416,"completionDateStruct":418,"leadSponsor":420,"locationsCount":69},"100551957","just-in-time-adaptive-interventions-for-diabetic-patients-100551957","NCT06466837","Just-In-Time Adaptive Interventions for Diabetic Patients","Promoting Self-management Behaviours Among Older Adults With Diabetes Mellitus by Integrating Just-In-Time Adaptive Interventions in Mobile Health Applications: A Randomized Controlled Trial","Inclusion Criteria:\n\n* With a confirmed DM diagnosis for one year or more than one year\n* Using governmental mhealth App\n* Living in an area with Internet coverage\n\nExclusion Criteria:\n\n* Already engaged in other mHealth programmes\n* Physical and cognitive limitations","60 Years",{"count":403,"type":23},184,[80],"The addition of proactive nurse consultations was useful to older adults with diabetes mellitus in facilitating their chronic disease self-management. However, the service is time and resource-intensive. With the support of advanced technology, mhealth App seems to be a convenient way to support patients in managing diabetes.",[407,408,27],"Diabetes","Self-Control",[410,411,412],"telecare","older adults","diabetes","2025-09-08",{"date":415,"type":32},"2025-09-15",{"date":417,"type":32},"2024-09-01",{"date":419,"type":23},"2026-03-01",{"name":421,"class":39},"The Hong Kong Polytechnic University",{"id":423,"slug":424,"hasResults":12,"nctId":425,"briefTitle":426,"officialTitle":427,"acronym":4,"eligibilityCriteria":428,"healthyVolunteers":18,"sex":180,"minAge":20,"maxAge":4,"enrollmentInfo":429,"targetDuration":4,"studyType":50,"phases":431,"briefSummary":432,"conditions":433,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":437,"lastUpdatePostDateStruct":438,"startDateStruct":440,"completionDateStruct":442,"leadSponsor":444,"locationsCount":69},"100602501","remote-cardiotocography-telemonitoring-within-high-risk-pregnancy-care-100602501","NCT07124325","Remote Cardiotocography Telemonitoring Within High-risk Pregnancy Care","The Use of Remote Cardiotocography Telemonitoring Within High-risk Pregnancy Care.","Inclusion Criteria:\n\n* Women aged ≥18 years\n* Gestational age 32+0 weeks onwards.\n* Singleton pregnancy.\n* Able to speak English\n* Receiving antenatal care which includes routine antenatal fetal monitoring for one of the 6 index conditions (hypertensive disease in pregnancy, reduced fetal growth (small for gestational age and fetal growth restriction) obstetric cholestasis, PPROM, previous history of stillbirth and recurrent reduced fetal movements )\n* Able to give written informed consent.\n* Willing to attend hospital immediately in the event of an unexpected finding whilst using the home devices.\n\nExclusion Criteria:\n\n* Multiple pregnancy.\n* Fetal abnormalities or a non-viable fetus.\n* Body mass index (BMI) ≥35\n* Women with internal cardiac devices such as pacemaker and implantable cardioverter defibrillator.\n* History of allergic reaction to skin adhesives and\u002For latex.\n* Acute or chronic skin lesions and wounds in areas in contact with the device.",{"count":430,"type":23},50,[80],"The overall aim of this research proposal is to explore the feasibility and acceptability of home antenatal maternal-fetal monitoring technology within a high-risk pregnancy group. The investigators hypothesise that home monitoring is feasible and acceptable to both pregnant women and HCPs.\n\n50 women from a single site will be recruited to use a home cardiotocography (CTG) device alongside routine antenatal care. Participants will use this device once a week, for an hour at a time, for up to 6 weeks or until delivery. The primary outcome is 20 minutes of continuous monitoring. Additional outcomes assess acceptability, adherence and safety.",[186,434,435,27,436],"High Risk","Telemonitoring","Cardiotocography","2025-08-08",{"date":439,"type":32},"2025-08-15",{"date":441,"type":32},"2025-06-11",{"date":443,"type":23},"2026-04-01",{"name":445,"class":446},"Birmingham Women's NHS Foundation Trust","OTHER_GOV",{"id":448,"slug":449,"hasResults":12,"nctId":450,"briefTitle":451,"officialTitle":452,"acronym":453,"eligibilityCriteria":454,"healthyVolunteers":12,"sex":19,"minAge":4,"maxAge":455,"enrollmentInfo":456,"targetDuration":4,"studyType":50,"phases":458,"briefSummary":459,"conditions":460,"keywords":462,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":464,"lastUpdatePostDateStruct":465,"startDateStruct":467,"completionDateStruct":469,"leadSponsor":471,"locationsCount":69},"100476207","improving-nighttime-access-to-care-and-treatment-part-4-haiti-100476207","NCT05480930","Improving Nighttime Access to Care and Treatment; Part 4-Haiti","Novel Approach to Improve Patient Care and Diarrheal Disease Research Using Mobile Technology in Haiti","INACT4-H","Inclusion criteria for child, parent\u002Fguardian participants:\n\n* Children 10 years of age or younger with an acute illness\n* Parent\u002Fguardian contacts the TMDS in regards to the illness during hours of operation\n* Parental\u002Fguardian agreement to a waiver of documentation of consent when contact is by phone only OR written consent\u002Fassent at the household from the parent\u002Fguardian and child (7yrs and older) for participants who receive a household visit.\n\nExclusion criteria for child, parent\u002Fguardian participants:\n\n* No consent","10 Years",{"count":457,"type":23},7124,[80],"Children in resource-limited settings who develop illness at night are often isolated from care, resulting in progression to an emergency. A telemedicine and medication delivery service (TMDS) is a viable healthcare delivery option to bridge the gap in nighttime care. This interrupted time series study (pre\u002Fpost) will evaluate a digital clinical decision-support (dCDS) tool. The objective is to assess if the tool is associated with an improvement in guideline adherence by TMDS providers.",[27,461],"Pediatrics",[463],"digital clinical decision support","2025-06-26",{"date":466,"type":32},"2025-06-30",{"date":468,"type":32},"2022-09-27",{"date":470,"type":23},"2027-09",{"name":472,"class":39},"University of Florida",{"id":474,"slug":475,"hasResults":12,"nctId":476,"briefTitle":477,"officialTitle":477,"acronym":478,"eligibilityCriteria":479,"healthyVolunteers":12,"sex":19,"minAge":20,"maxAge":4,"enrollmentInfo":480,"targetDuration":4,"studyType":24,"phases":4,"briefSummary":482,"conditions":483,"keywords":485,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":486,"lastUpdatePostDateStruct":487,"startDateStruct":489,"completionDateStruct":490,"leadSponsor":492,"locationsCount":494},"100591462","video-tumorboard-plus-100591462","NCT06980740","Video-Tumorboard PLUS","vTB+","Inclusion Criteria:\n\n* The study includes adult, external patients who, according to the certification requirements of the German Cancer Society, should be presented to the CCCs in a tumor board .\n\nInclusion criteria for patients:\n\n* Minimum age 18 years\n* Consent to participate in the study (signing of patient consent) should be presented in vTB+ according to the doctor, based on the disease\u002Fdiagnosis, especially in the case of:\n\n  * Malignant melanoma from stage IIB\n  * Malignant melanoma and stage shift\u002Frecurrence o Extracutaneous melanoma o Cutaneous lymphoma from stage Ib o Problem cases with malignant, epithelial tumors (BCC, SCC) with interdisciplinary issues, e.g. complicated localization, extension\u002F infiltration (e.g. Ulcus rodens, Ulcus terebrans), metastasized tumors, immunosuppressed patients o all rare malignant skin tumors (including Merkel cell carcinoma, DFSP, MFH, leiomyosarcoma, S., Kaposi's sarcoma, angiosarcoma), regardless of stage o severe side effects from drug-based tumor therapy • is an external patient: An external patient is someone who receives tumor therapy exclusively or in co-treatment in the branch or in an external clinic (in distinction to patients without prior treatment for initial presentation at the CCC) . This also applies to patients who are only seen once at the vTB.\n\nIn this case, revenue\u002Fcost aspects and the DKG requirement are ignored. This means that so-called external patients can also be treated at the center, including initiation of therapy. The decisive factor is the presentation of the external patient (personal presentation of the external patients is not mandatory) and that external co-treaters are consistently informed and involved.\n\nInclusion criteria for external doctors:\n\n* has a medical license\n* has dermatological patients who are eligible to be presented in the vTB+\n\nExclusion Criteria:\n\nPatients will be excluded from the study if they meet the following criteria:\n\n* Linguistic or other limitations (such as dementia) that prevent independent consent to the privacy policy.\n* No consent to participate in the study (patient consent) or withdrawal of consent during the course of the study In addition, external physicians will be excluded from the study if no joint cooperation agreement can be negotiated and signed.",{"count":481,"type":23},300,"In weekly expert meetings for oncological diagnostics and therapy, known as tumor boards, individual therapy recommendations are developed for cancer patients. By further developing and optimizing the CCCs' video tumor boards, initially using skin cancer as an example, we want to ensure that more patients can benefit from the expertise of several specialist disciplines and innovations - regardless of where they live.",[484,27],"Malignant Melanoma",[484,27],"2025-05-16",{"date":488,"type":32},"2025-05-20",{"date":320,"type":32},{"date":491,"type":23},"2027-05-31",{"name":493,"class":39},"University Hospital Muenster",3,{"id":496,"slug":497,"hasResults":12,"nctId":498,"briefTitle":499,"officialTitle":500,"acronym":4,"eligibilityCriteria":501,"healthyVolunteers":12,"sex":180,"minAge":20,"maxAge":502,"enrollmentInfo":503,"targetDuration":4,"studyType":50,"phases":505,"briefSummary":506,"conditions":507,"keywords":4,"overallStatus":161,"whyStopped":4,"lastUpdateSubmitDate":511,"lastUpdatePostDateStruct":512,"startDateStruct":514,"completionDateStruct":516,"leadSponsor":518,"locationsCount":69},"100591333","health-education-for-women-with-suspeced-infertility-waiting-for-specialized-care-100591333","NCT06979063","Health Education for Women With Suspeced Infertility Waiting for Specialized Care","Impact of Regulation Strategies and Health Education for Managing Infertility in Primary Health Care in Rio Grande do Sul","Inclusion Criteria:\n\n* Individuals referred to specialized infertility care in Porto Alegre.\n* Age up to 33 years and 11 months.\n\nExclusion Criteria:\n\n* Lack of access to the internet or telephone.\n* Prior specialized infertility treatment in the private healthcare system.","34 Years",{"count":504,"type":23},206,[80],"Introduction: Infertility is defined as a couple's inability to achieve pregnancy after 12 months or more of regular unprotected intercourse. In Brazil, it affects around eight million people. While health services provide resources for contraception, little attention is given to supporting conception and preserving fertility.\n\nObjective: To evaluate the effectiveness of a remote educational and counseling intervention on infertility.\n\nMethod: Open-label randomized clinical trial. Couples referred for infertility will be identified in the electronic referral system. For inclusion, the woman of the couple must be 34 years old or less, no previous in-vitro fertilization attempts, and have access to telephone or internet. The control group will follow standard care, awaiting in-person consultation. The intervention group will also wait for in-person evaluation but receive additional education and counseling via video call.\n\nThe primary outcome is the proportion of correct referrals according to local protocols. A total of 206 participants will be included to detect a difference between success rates of 50% and 30%, with 80% power and a 5% significance level.",[508,509,27,510],"Infertility","Health Education","Telehealth","2025-05-12",{"date":513,"type":32},"2025-05-18",{"date":515,"type":23},"2025-06",{"date":517,"type":23},"2026-12-31",{"name":519,"class":39},"Hospital de Clinicas de Porto Alegre",{"id":521,"slug":522,"hasResults":12,"nctId":523,"briefTitle":524,"officialTitle":524,"acronym":4,"eligibilityCriteria":525,"healthyVolunteers":12,"sex":526,"minAge":309,"maxAge":115,"enrollmentInfo":527,"targetDuration":4,"studyType":50,"phases":529,"briefSummary":530,"conditions":531,"keywords":534,"overallStatus":161,"whyStopped":4,"lastUpdateSubmitDate":511,"lastUpdatePostDateStruct":539,"startDateStruct":540,"completionDateStruct":542,"leadSponsor":544,"locationsCount":69},"100591484","the-effectiveness-of-telemedicine-monitoring-prehabilitation-in-prostate-cancer-patients-undergoing-radical-prostatectomy-100591484","NCT06981026","The Effectiveness of Telemedicine Monitoring Prehabilitation in Prostate Cancer Patients Undergoing Radical Prostatectomy","Inclusion criteria:\n\n* Biopsy-confirmed localized prostate cancer (ICD code C.61).\n* Indicated for radical prostatectomy, with or without pelvic lymphadenectomy (ePLND).\n* Not previously treated for prostate cancer, including radiation therapy to the pelvis, major pelvic surgery, or placement of a penile implant or artificial urinary sphincter.\n* No known urethral stricture or colostomy or chronic urinary catheterization.\n* No medical or current psychiatric disorders that precludes their participation in the study.\n* Status of the musculoskeletal system allowing physical exercise.\n* Urinary continent at baseline.\n* Has reliable internet and the skills\u002Fknowledge to use technologies use for the study.\n\nExclusion criteria:\n\n* Other malignant tumors, except for benign skin carcinoma.\n* Active treatment for other oncological diagnoses.\n* Presence of preoperative urinary incontinence.\n* Diagnosed mental or cognitive disorders.\n* Prior pelvic radiotherapy or hormone therapy for prostate cancer recurrence.\n* Severe musculoskeletal disorders preventing active exercise\n* Inability to use required technologies","MALE",{"count":528,"type":23},200,[80],"The study titled \" The effectiveness of telemedicine monitoring prehabilitation in prostate cancer patients undergoing radical prostatectomy \" investigates the impact of a structured telemedicine-supported prehabilitation and rehabilitation program on reducing postoperative urinary incontinence in patients with localized prostate cancer. Radical prostatectomy, a common treatment for localized prostate cancer, is often associated with complications such as urinary incontinence, which significantly affects quality of life. This study aims to address this issue by enhancing patients' physical conditioning and adherence to pre- and postoperative rehabilitation through the use of wearable devices and remote physiotherapy consultations.",[532,533,27],"Prostatectomy","Prehabilitation",[532,535,27,536,537,533,538],"Physiotherapy","eHealth","Oncology","Rehabilitation",{"date":488,"type":32},{"date":541,"type":23},"2026-01-01",{"date":543,"type":23},"2028-09-30",{"name":545,"class":39},"University Hospital Olomouc",{"id":547,"slug":548,"hasResults":12,"nctId":549,"briefTitle":550,"officialTitle":551,"acronym":4,"eligibilityCriteria":552,"healthyVolunteers":12,"sex":19,"minAge":20,"maxAge":553,"enrollmentInfo":554,"targetDuration":4,"studyType":50,"phases":556,"briefSummary":557,"conditions":558,"keywords":560,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":564,"lastUpdatePostDateStruct":565,"startDateStruct":567,"completionDateStruct":569,"leadSponsor":571,"locationsCount":69},"100590554","effectiveness-of-a-home-based-rehabilitation-program-in-stroke-survivors-using-the-euleria-home-device-100590554","NCT06968923","Effectiveness of a Home-Based Rehabilitation Program in Stroke Survivors Using the Euleria Home® Device","Effectiveness of a Home-Based Rehabilitation Program in Stroke Survivors Using the Euleria Home® Device: A Crossover Study.","Inclusion Criteria:\n\n* Age over 18 years.\n* First diagnosis of ischemic stroke, documented radiologically via CT or MRI scans, corresponding to ICD-9-CM codes 433 and 434 .\n* Presence of aphasia, as assessed by the Aachener Aphasia Test (AAT), and\u002For cognitive deficits identified through the Oxford Cognitive Screen (OCS).\n* Availability of an ADSL or higher-speed internet connection at the patient's residence.\n* Ability of the patient and\u002For caregiver to understand and utilize the telerehabilitation system.\n* Provision of written informed consent.\n\nExclusion Criteria:\n\n* Contemporanea partecipazione ad altri studi clinici;\n* Decadimento cognitivo\n* Deformità ossee come conseguenza di precedenti eventi traumatici ai 4 arti;\n* Contratture fisse ai 4 arti valutate come 4\u002F4 alla scala di Ashworth modificata (MAS)\n* Altre patologie neurologiche e ortopediche in grado di interferire con lo studio.","90 Years",{"count":555,"type":23},90,[80],"To verify the non-inferiority, in terms of post-treatment (T1) clinical effectiveness, of a \"multidomain\" telerehabilitation (TR) protocol compared to conventional outpatient rehabilitation in patients with stroke sequelae, with respect to motor, cognitive, and language functions. The absence of statistically significant differences between the two groups regarding treatment effects for each targeted domain will be considered an indicator of non-inferiority.",[559,27,538,157],"Stroke",[559,93,561,562,563],"telerehabilitation","motor","cognitive","2025-05-05",{"date":566,"type":32},"2025-05-13",{"date":568,"type":32},"2018-04-26",{"date":570,"type":23},"2026-04",{"name":572,"class":39},"Universita di Verona",{"id":574,"slug":575,"hasResults":12,"nctId":576,"briefTitle":577,"officialTitle":578,"acronym":579,"eligibilityCriteria":580,"healthyVolunteers":12,"sex":19,"minAge":581,"maxAge":582,"enrollmentInfo":583,"targetDuration":4,"studyType":50,"phases":585,"briefSummary":586,"conditions":587,"keywords":592,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":597,"lastUpdatePostDateStruct":598,"startDateStruct":600,"completionDateStruct":601,"leadSponsor":603,"locationsCount":69},"100584502","onestop-one-stop-telehealth-obesity-program-for-multidisciplinary-weight-management-and-related-comorbidities-100584502","NCT06890169","OneSTOP (One-Stop Telehealth Obesity Program) for Multidisciplinary Weight Management and Related Comorbidities","OneSTOP (One-Stop Telehealth Obesity Program): the Use of Telecare and Digital Platforms for Multidisciplinary Management of Weight Management and Related Comorbidities","OneSTOP","Inclusion Criteria:\n\n* Adults aged 21-70\n* Body mass index \\> 27.5 kg\u002Fm2\n* Waist circumference \\> 90 cm in men or 80 cm in women\n* Suboptimal control of type 2 diabetes (HbA1c \\> 6.5%) AND\u002FOR MASLD (as defined on radiological or histological evidence of hepatic steatosis in the absence of other chronic liver disease)\n\nExclusion Criteria:\n\n* Men who drink \\> 21 units\u002Fweek and women who drink \\> 14 units\u002Fweek of alcohol\n* Participants previously on weight-lowering medications (however if they are keen to participate, there will be a minimum wash-out period of 3 months before participation)\n* Illness with life expectancy of less than 6 months\n* Inability to comply with written instructions in English","21 Years","70 Years",{"count":584,"type":23},120,[80],"The goal of this clinical trial is to learn if the use of a care model including teleconsults and the EMPOWER app can induce clinically significant weight loss and metabolic improvements in obese adults with diabetes and metabolic dysfunction-associated steatotic liver disease (MASLD).\n\nResearchers will compare this model with the conventional standard of care of physical visit-based weight management program to see if this model is non-inferior to the standard of care for inducing weight loss, and if there is greater patient convenience with telehealth and more frequent self-monitoring, compliance with diet advice and exercise participation compared to standard of care.\n\nParticipants in the standard arm will attend 4 physical doctor and 4 physical dietician consultations over 26 weeks, where they will be provided with an individualized diet and exercise prescription to induce at least 5% weight loss.\n\nParticipants in the intervention arm will have the same number of consults over 26 weeks, of which at least 50% will be teleconsults, and will also be provided with an individualized diet and exercise prescription to induce at least 5% weight loss. In addition, they will be taught to use the EMPOWER app to upload weight, blood pressure and glucose, food and exercise records which will be reviewed at the consults. The app also delivers nudges to improve adherence to lifestyle modification.",[588,589,590,591,27],"Obesity and Type 2 Diabetes","NAFLD - Non-Alcoholic Fatty Liver Disease","Hypertension","Dyslipidaemia",[593,594,595,596,410,93],"obesity","type 2 diabetes","masld","nafld","2025-03-17",{"date":599,"type":32},"2025-03-21",{"date":320,"type":23},{"date":602,"type":23},"2027-08-31",{"name":604,"class":39},"Changi General Hospital",{"id":606,"slug":607,"hasResults":12,"nctId":608,"briefTitle":609,"officialTitle":610,"acronym":611,"eligibilityCriteria":612,"healthyVolunteers":12,"sex":19,"minAge":20,"maxAge":4,"enrollmentInfo":613,"targetDuration":4,"studyType":50,"phases":615,"briefSummary":616,"conditions":617,"keywords":618,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":620,"lastUpdatePostDateStruct":621,"startDateStruct":623,"completionDateStruct":625,"leadSponsor":627,"locationsCount":69},"100574919","video-versus-face-to-face-preoperative-anaesthetic-assessment-100574919","NCT06765538","Video Versus Face-to-face Preoperative Anaesthetic Assessment","Video Versus Face-to-face Preoperative Anaesthetic Assessment: a Randomized Clinical Trial on Safety and User Satisfaction","VIDFACE","Inclusion Criteria:\n\n* ENT and TMJ patients\n* Adults \\> 18 years\n* Informed consent obtained after a consideration period of minimum 24 hours\n\nExclusion Criteria:\n\n* If a patient is assessed unsuitable for the video technology in example, patients with severe mental challenges (dementia, retardation, etc.), they will not be included in the trial. If excluded, the patient receives standard care, face-to-face preoperative anaesthetic assessment.\n* Local protocol screen patients",{"count":614,"type":23},2260,[80],"Randomized clinical trial rewieving difference between anaesthetic preassessment in physical consultations vs. video consultations.",[187,27],[619,93],"anaesthetic preassessment","2025-01-30",{"date":622,"type":32},"2025-02-03",{"date":624,"type":32},"2024-11-04",{"date":626,"type":23},"2026-11-30",{"name":628,"class":39},"Rigshospitalet, Denmark",{"id":630,"slug":631,"hasResults":12,"nctId":632,"briefTitle":633,"officialTitle":634,"acronym":635,"eligibilityCriteria":636,"healthyVolunteers":18,"sex":180,"minAge":20,"maxAge":4,"enrollmentInfo":637,"targetDuration":4,"studyType":50,"phases":639,"briefSummary":640,"conditions":641,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":643,"lastUpdatePostDateStruct":644,"startDateStruct":646,"completionDateStruct":648,"leadSponsor":649,"locationsCount":325},"100568502","telemedicine-contraceptive-counselling-tecc-versus-standard-care-100568502","NCT06682065","Telemedicine Contraceptive Counselling (TECC) Versus Standard Care","Telemedicine Contraceptive Counselling (TECC) Versus Standard Care - a Pilot and Randomized Controlled Trial of Periabortion Contraceptive Counseling","TECC","* Seeking either surgical or medical abortion\n* ≥ 18 years of age\n* Able to communicate and understand spoken and written English\n* With private access to a smart phone\n* Willing to participate in the study procedures",{"count":638,"type":23},510,[80],"Overall purpose of the PILOT and RCT:\n\nThis research project aims to increase access and uptake of contraception after abortion through the systematic development and testing of a new telemedicine service for contraceptive counselling (TECC). The investigators will perform a pilot study in South Africa, and multicenter randomized controlled trial in South Africa and Kenya with the following specific aims:",[642,27],"Contraceptive Usage","2024-11-08",{"date":645,"type":32},"2024-11-12",{"date":647,"type":32},"2024-05-05",{"date":265,"type":23},{"name":650,"class":39},"Karolinska Institutet",{"id":652,"slug":653,"hasResults":12,"nctId":654,"briefTitle":655,"officialTitle":655,"acronym":4,"eligibilityCriteria":656,"healthyVolunteers":12,"sex":19,"minAge":20,"maxAge":4,"enrollmentInfo":657,"targetDuration":4,"studyType":50,"phases":659,"briefSummary":660,"conditions":661,"keywords":665,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":668,"lastUpdatePostDateStruct":669,"startDateStruct":671,"completionDateStruct":673,"leadSponsor":674,"locationsCount":69},"100525019","impact-of-the-implementation-of-a-telemedicine-program-on-patients-diagnosed-with-asthma-100525019","NCT06116292","Impact of the Implementation of a Telemedicine Program on Patients Diagnosed with Asthma","Inclusion Criteria:\n\n* Age ≥18 years with a diagnosis of asthma based on GEMA 5.2 2022.\n* Patients seen in the pulmonology service of the center.\n* Patients who have not previously received asthma education.\n* Capable of giving signed informed consent.\n\nExclusion Criteria:\n\n* Patient who does not have a mobile device with Android or IOS system.\n* Lack of minimum technological knowledge for the use of the application (ESTOI).\n* People who are participating or have participated in a clinical trial in the last 6 months.\n* Patients diagnosed with other respiratory diseases except for obstructive sleep apnea (OSA), Asthma-COPD overlap syndrome (ACOS).\n* Patients with palliative or severe chronic illnesses that limit their life expectancy.",{"count":658,"type":23},108,[80],"Introduction: Asthma is one of the most common chronic respiratory diseases worldwide. Despite the extensive knowledge of the condition and available therapeutic options, severe asthmatic patients have poor disease control in 50% of cases.\n\nObjective: To assess the impact of implementing a mobile application (ESTOI) in patients diagnosed with asthma on disease control, treatment adherence, and perceived quality of life.\n\nMethodology: A 52-week randomized clinical trial involving asthma patients receiving care at a highly specialized hospital in Spain. A total of 108 patients will be included and divided into two groups. The intervention group will receive more comprehensive monitoring than usual, including access to the ESTOI application. The Asthma Control Test (ACT) questionnaire will be used as the primary assessment variable. Other variables to be studied include the Inhaler Adherence Test (TAI), the number of exacerbations, peak expiratory flow, exhaled nitric oxide examination, hospital anxiety and depression scale, asthma quality of life questionnaire, forced spirometry parameters (FVC, FEV1, and reversibility), and analytical parameters (eosinophilia and IgE).",[662,27,663,156,664],"Asthma","Adherence, Treatment","Control",[662,27,666,667,663],"Asthma Control","Quality of Live","2024-10-20",{"date":670,"type":32},"2024-10-22",{"date":672,"type":32},"2024-01-01",{"date":517,"type":23},{"name":675,"class":39},"Hospital Universitari de Bellvitge",{"id":677,"slug":678,"hasResults":12,"nctId":679,"briefTitle":680,"officialTitle":681,"acronym":682,"eligibilityCriteria":683,"healthyVolunteers":12,"sex":19,"minAge":684,"maxAge":4,"enrollmentInfo":685,"targetDuration":4,"studyType":24,"phases":4,"briefSummary":687,"conditions":688,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":689,"lastUpdatePostDateStruct":690,"startDateStruct":692,"completionDateStruct":694,"leadSponsor":696,"locationsCount":69},"100476432","telehealth-delivered-healthcare-to-improve-care-100476432","NCT05483855","Telehealth-delivered HealthcaRe to ImproVe Care","Telehealth-delivered HealthcaRe to ImproVe Care (THRIVE) as an Integral Component of Remote Therapeutic Monitoring (RTM)","THRIVE","Inclusion Criteria:\n\n* Must be 19 years or older.\n* Must have a prior diagnosis of Rheumatoid Arthritis.\n* Must be able to read and write in English or Spanish.\n\nExclusion Criteria:\n\n* Younger than 19 years of age\n* Does not have a prior diagnosis of Rheumatoid Arthritis.\n* Unable to read and write in English or Spanish","19 Years",{"count":686,"type":23},1580,"Objective 1:\n\nEvaluate patients' satisfaction with their telehealth care and determine factors associated with satisfaction.\n\nObjective 2:\n\nDeploy PROs and patient self-assessment tools, specifically a patient-facing instructional in-app tool that instructs RA patients how to perform self-assessment examinations to observe and report the number of tender and swollen joint counts.",[27],"2024-08-05",{"date":691,"type":32},"2024-08-06",{"date":693,"type":32},"2023-01-03",{"date":695,"type":23},"2025-04",{"name":697,"class":106},"Attune Health Research, Inc.",{"id":699,"slug":700,"hasResults":12,"nctId":701,"briefTitle":702,"officialTitle":703,"acronym":4,"eligibilityCriteria":704,"healthyVolunteers":12,"sex":19,"minAge":705,"maxAge":706,"enrollmentInfo":707,"targetDuration":4,"studyType":50,"phases":709,"briefSummary":710,"conditions":711,"keywords":4,"overallStatus":161,"whyStopped":4,"lastUpdateSubmitDate":713,"lastUpdatePostDateStruct":714,"startDateStruct":716,"completionDateStruct":718,"leadSponsor":720,"locationsCount":4},"100491710","luchtbrug-junior-the-next-step-100491710","NCT05682664","Luchtbrug Junior: the Next Step","Luchtbrug Junior: Online Monitoring for Young Children With Preschool Wheeze","Inclusion criteria\n\n* Children aged 2 to 6 years with a doctor's diagnosis of preschool wheeze\n* Children have an indication for regular follow-up of at least one year by a paediatrician because of respiratory symptoms;\n* Children are treated with inhaler medication, including inhaled corticosteroids;\n* A history of three episodes of wheezing managed by a healthcare professional of which at least one was observed by a paediatrician in the last 12 months prior to the study, or:\n* At least one hospital admissions due to pulmonary symptoms before inclusion.\n* Informed consent of parents\u002Fcaregivers\n\nExclusion criteria\n\n* Underlying chronic cardiopulmonary or neuromuscular condition, or known recurrent aspirations;\n* Underlying syndromes associated with pulmonary comorbidities;\n* Prematurity \\\u003C36 weeks after gestation;\n* Inability of parents\u002Fcaregivers\u002Fcaretakers to understand and\u002For read Dutch;\n* No access to a smartphone and\u002For internet.","2 Years","6 Years",{"count":708,"type":23},270,[80],"Rationale:\n\nThe introduction of e-health in the monitoring and management of patients with chronic conditions can be beneficial and efficient. The introduction of an online monitoring and management tool, \"Luchtbrug\", for children 6-16 yrs of age with asthma while reducing 50% of visits to the outpatient clinic, results in similar or improved asthma control while reducing costs. It is highly likely that this concept of e-health is suitable for other chronic conditions. Therefore the aim of the study is to investigate the added value of online monitoring and management of children with preschool wheeze (2-6 yrs of age).\n\nObjective: To assess whether the number of symptom free days can be improved using online monitoring and disease management via Luchtbrug Junior, while reducing the number of outpatient clinic visits by 50%\n\nStudy design: Prospective multicentre (n=6) randomised trial in which disease management via Luchtbrug Junior will be compared with usual care.\n\nFollow-up: 12 months.\n\nStudy population: children aged 2-6 yrs with preschool wheezing (multiple episode of cough, wheeze and dyspnoea).\n\nIntervention (if applicable): Children will be randomised into usual care (n=135) or partly online care via Luchtbrug Junior (n = 135)\n\nMain study parameters\u002Fendpoints:\n\nPrimary objective: Number of symptom free days (SFDs) based on the TRACK questionnaire, during the last four weeks of the study (measured at 12 months).\n\nSecondary objectives:\n\nHealthcare consumption: unscheduled visits Emergency Department (ED) or outpatient clinic, unscheduled phone calls, hospital admissions) Questionnaires into: Quality of Life (QoL), cost-effectiveness (direct and indirect costs), self-management of patients, adherence to treatment, satisfaction of parents\u002Fcaregivers.\n\nUsual care consists of regular visits to the outpatient clinic every 3 months after starting the study. In between visits contact with the healthcare team is by telephone as needed. At 3, 6, 9 and 12 months, patients will be asked to complete the TRACK questionnaire.\n\nOnline care using Luchtbrug Junior will include visits to the outpatient clinic every 6 months after starting the study. In between visits, parents\u002Fcaregivers of the patient will be asked to answer the digital version of TRACK questionnaire monthly, therefore the parents\u002Fcaregivers will received email-reminders. Appropriate feedback on their TRACK-scores will be provided by their healthcare team within two working days. Any interventions such as adjustment of treatment are at the judgment of the treating pediatrician. Therapy adherence will be monitored during the study by using smart inhalers.",[536,27,712],"Wheezing","2024-06-07",{"date":715,"type":32},"2024-06-10",{"date":717,"type":23},"2024-08-01",{"date":719,"type":23},"2027-02-01",{"name":721,"class":39},"Radboud University Medical Center"]